Close Menu

MDVIP

NEW YORK (GenomeWeb) – Exact Sciences today announced that physicians network MDVIP will make Exact's ColoGuard colorectal cancer screening test available to its affiliated nationwide network of more than 750 primary care physicians.

Bernadette Toner provided reporting for this article from Los Angeles. In acquiring genetic testing services firm Navigenics, Life Technologies has garnered capabilities that will enable it to formally enter the molecular diagnostics space.

Navigenics’ lower-priced program to incorporate genetic risk data in patients’ annual medical checkup raises questions as to whether personal genomics firms should be broadly marketing their services to physicians.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.